Renal-limited AL amyloidosis – a diagnostic and management dilemma
Sign Up to like & getrecommendations! Published in 2018 at "BMC Nephrology"
DOI: 10.1186/s12882-018-1118-8
Abstract: BackgroundAmyloidosis is a disorder caused by extracellular tissue deposition of insoluble fibrils which may result in a wide spectrum of symptoms depending upon their types, sites and amount of deposition. Amyloidosis can be divided into… read more here.
Keywords: diagnostic management; amyloidosis diagnostic; limited amyloidosis; amyloidosis ... See more keywords
Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report
Sign Up to like & getrecommendations! Published in 2021 at "BMC Nephrology"
DOI: 10.1186/s12882-021-02386-y
Abstract: Background Gemcitabine and cisplatin are chemotherapeutic agents used for treating multiple cancers, and these agents are sometimes used in combination. Drug-induced thrombotic microangiopathy (TMA) is a rare but potentially fatal complication. It typically presents as… read more here.
Keywords: gemcitabine dexamethasone; cisplatin therapy; cisplatin; dexamethasone cisplatin ... See more keywords